Daily Morning Note – 2 March 2022

Welcome to our Daily Morning Note from our Research team!


Stocks are set to come under more pressure Wednesday as the war in Ukraine and sanctions on Russia stoke the cost of commodities including oil, dimming the growth outlook and boosting demand for sovereign bonds.

Futures for Japan, Australia and Hong Kong fell after Wall Street and European shares retreated. Australian debt joined a global rally in fixed income that lowered the 10-year U.S. Treasury yield to 1.73%. Gold and the dollar advanced.

Crude soared as steps to tap reserves failed to ease worries about shortfalls as penalties mount on resources-rich Russia for the invasion of its neighbor.

Stocks to watch: Sea Limited

Top gainers & losers




Singapore-based Sea, which owns e-commerce platform Shopee and games developer Garena, widened its net loss excluding share-based compensation attributable to ordinary shareholders of US$1.5 billion for FY2021 ending Dec 31, up 17.9 per cent from US$1.3 billion a year prior. In a filing on Tuesday (Mar 1), the New York Stock Exchange-listed company reported a 127.5 per cent increase in FY2021 revenue from US$4.4 billion to US$9.9 billion. The increase is driven by growth across all business segments. Loss per share in FY2021 rose 6.5 per cent from US$2.78 to US$2.96.

Industrial agri-food company Japfa on Tuesday (Mar 1) posted a 63 per cent dip in net profit to US$118.8 million for the full year to December 2021, dragged by its Animal Protein Others (APO) segment. This brought Japfa’s earnings per share for the full-year to 5.82 US cents, down from 15.86 US cents the previous year. Excluding the one-off extraordinary net gain of US$140.2 million from the sale of 80 per cent in Dairy South-east Asia in 2020, however, net profit would have been down 34.6 per cent. This was despite a 20 per cent rise in revenue from US$3.9 billion to US$4.6 billion led by higher sales volumes across all segments. The increase in revenue also cushioned the impact of the drop in profit margins as a result of higher feed raw materials costs.

The Singapore Exchange Regulation Company (SGX RegCO) has laid out expectations of what needs to be disclosed about a valuation of an asset for significant transactions. SGX-listed companies should explain how the transaction will benefit the company’s long-term business strategy and its merits to investors. Companies are reminded that they must disclose: The value ascribed to the assets; The party who commissioned the valuation; The basis including the underlying methodologies and assumptions in arriving at the valuation; and The date of the valuation.

Logistics management service provider Cosco Shipping reported a surge of 261 per cent for its FY2021 earnings to S$30.1 million from S$8.3 million a year prior. The mainboard listed company reported a 7 per cent y-o-y increase in FY2021 revenue to S$198.5 million from S$185.8 million in a filing on Tuesday evening (Mar 1). Earnings per share for FY2021 also jumped from 0.37 Singapore cents per share to 1.34 Singapore cents per share. The growth in revenue was driven by higher revenue from logistics and ship repair and marine engineering activities. This was partially offset by lower revenue from shipping and property management. Logistics activities make up the bulk of Cosco’s revenue at 74 per cent.


US payment card firms Visa and MasterCard have blocked multiple Russian financial institutions from their network, complying with government sanctions imposed over Moscow’s invasion of Ukraine. Visa said on Monday (Feb 28) it was taking prompt action to ensure compliance with applicable sanctions, adding that it will donate US$2 million for humanitarian aid. Mastercard also promised to contribute US$2 million. “We will continue to work with regulators in the days ahead to abide fully by our compliance obligations as they evolve,”Mastercard said in a separate statement late on Monday.

American manufacturing firms continued to see growth accelerate as demand rose in February, but the expansion was again constrained by supply chain issues and labour shortages, according to an industry survey released Tuesday. The Institute for Supply Management (ISM) said its manufacturing index rose a full point to 58.6 last month, pushed by a 3.8-point jump in new orders and a solid gain in production. Any reading above 50 per cent indicates growth. But the Covid-19 pandemic continued to be felt and the survey showed the backlog of orders posted its biggest increase since 2011 while inventories fell.

Members states of the International Energy Agency (IEA) agreed on Tuesday to release 60 million barrels from oil reserves, Japan’s industry minister said, as the US and its allies seek to cool oil prices soaring from Russia’s invasion of Ukraine. Half the volume will come from the United States, Koichi Hagiuda told reporters after the extraordinary ministerial meeting of the 31 members of the IEA, which represents mostly industrialised nations. “We have agreed that IEA (members) as a whole will make a coordinated oil release of 60 million barrels in total,” Hagiuda told reporters.

Peabody Energy, the biggest US coal producer, is expanding into clean energy. The St Louis-based company is forming a joint venture with Riverstone Credit Parters and Summit Partners Credit Advisors to develop utility-scale solar projects on land around previous coal mining operations, according to a statement Tuesday. The move is a notable shift for a company that has been digging up the dirtiest fossil fuel since its founding in 1883, and comes as utilities around the world increasingly shift to cleaner energy sources to combat climate change. While coal is enjoying a surge in demand during the past six months, that’s seen as a short-term trend as the global economy emerges from the coronavirus pandemic. The long-term trends for coal remain grim, and Peabody characterised the decision as a way to generate new revenue sources.

While US drugmakers like Pfizer and Moderna made a killing from Covid-19 mRNA vaccine sales last year, sustaining similar volumes this year will be a challenge as more parts of the world become fully vaccinated. At their 2021 results briefings last month, both drugmakers said they expect Covid-19 to enter the endemic phase this year, but regular booster shots will be needed to protect the public from new infections. Moving forward, the two companies will roll out new booster shots and vaccines for younger age groups to support revenues. Both Pfizer and Moderna announced that they are in various stages of developing and commercialising new boosters and vaccines that will lower the risk of hospitalisation as a result of Omicron, citing data from studies showing that protection offered by existing boosters against the now-dominant variant is likely to wane after six months of administration.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, CNBC, PSR


HRnetGroup Limited – Another record year expected

Recommendation: BUY (Maintained); TP S$1.18, Last close: S$0.775; Analyst Paul Chew

– Results beat our estimates. FY21 revenue and PATMI was 114%/108% of our forecast. 2H21 PATMI grew 14% YoY to S$29.6mn. Excluding fair value losses, PATMI would have jumped 37%.

– 2H21 growth was from both permanent recruitment (+36% YoY) and flexible staffing (+43% YoY). FY21 DPS increased 60% to 4 cents, including a 1 cent special dividend.

– We expect another record year in FY22e. Volume growth in permanent hires will come from recovering economic conditions and clients working more with recruiters due to the tight labour market. Rising salaries will be the driver for higher margins. Flexible staffing remains healthy as others sectors start to re-open. We maintain BUY. Our target price is raised to S$1.18 (previous S$1.05) as we raise FY22e earnings by 20%. The valuation metric is lowered from 14x to 12x PE FY22e ex-cash. We tag to the mid-range of the historical 5-year range as the labour recovery has moved past the peak cycle. HRnet pays a dividend yield of 5%, net cash of S$327mn and unlevered ROEs of 16% (or above 100% ex-cash).

BHG Retail REIT – Stable growth with resilient portfolio

(Non-rated); TP: N/A
Last Done: S$0.545; Analyst: Vivian Ye

– Committed occupancy improved to 97.0% from 93.5% in 2H20 as four portfolio assets saw recovery.

– Gross revenue and net property income increased by 10.8% and 6.6% YoY respectively. 2H21 DPU was up by 4% to 1.05 Scts.

POEMS Podcast: Let the Money Talk

Recent Podcasts:

Money Never Sleeps Ep 04

Ascott Residence Trust – SGX Company Insights Ep 42

Ascendas REIT – SGX Company Insights Ep 41

Visit www.stocksbnb.com to learn more!


Join our Phillip Securities Research Telegram channel for the latest update on our stock coverage!

Click the link to join: https://t.me/stocksbnb


Weekly Market Outlook: UOB, OCBC, Lendlease, FSG, RMG, Propnex, SSG, Venture, Wilmar, Nanofilm…

Date: 28 February 2022

Click here for more on Market Outlook

Sign up for our webinars here, and be among the first to receive economy and market updates.

HK Reports – Read up on our Hong Kong reports here

Updates summarised in 3 minutes

Phillip Research in 3 minutes: #29

Keppel Corporation; Initiation

Click here for more videos on Phillip in 3 Mins

For any research-related matters, email: research@phillip.com.sg

For general enquiries, email: talktophillip@phillip.com.sg
or call 6531 1555.

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information


The information contained in this email is provided to you for general information only and is not intended to create any binding legal relation. The information or opinions provided in this email do not constitute investment advice, a recommendation, an offer or solicitation to subscribe for, purchase or sell any investment product. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise.

You should obtain advice from a financial adviser before making a commitment to invest in any investment product or service. In the event that you choose not to obtain advice from a financial adviser, you should assess and consider whether the investment product or service is suitable for you before proceeding to invest.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com